Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer

To evaluate the feasibility of amrubicin plus cisplatin (AP) following chemoradiotherapy for limited‐disease small‐cell lung cancer, chemo‐naïve patients aged 20–70 years with a performance status of 0 or 1 and normal organ functions were treated with etoposide 100 mg/m(2) on days 1–3, cisplatin 80...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekine, Ikuo, Sumi, Minako, Satouchi, Miyako, Tsujino, Kayoko, Nishio, Makoto, Kozuka, Takuyo, Niho, Seiji, Nihei, Keiji, Yamamoto, Nobuyuki, Harada, Hideyuki, Ishikura, Satoshi, Tamura, Tomohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814250/
https://www.ncbi.nlm.nih.gov/pubmed/26748638
http://dx.doi.org/10.1111/cas.12875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814250/
https://www.ncbi.nlm.nih.gov/pubmed/26748638
http://dx.doi.org/10.1111/cas.12875

Ejemplares similares